These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8302303)

  • 1. Neurotoxins and monoamine oxidase inhibition: new aspects.
    Finnegan KT
    Mov Disord; 1993; 8 Suppl 1():S14-9. PubMed ID: 8302303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B.
    Finnegan KT; Skratt JJ; Irwin I; DeLanney LE; Langston JW
    Eur J Pharmacol; 1990 Aug; 184(1):119-26. PubMed ID: 2120076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of some monoamine oxidase-B inhibitors against DSP-4-induced noradrenaline depletion in the mouse hippocampus.
    Yu PH; Davis BA; Fang J; Boulton AA
    J Neurochem; 1994 Nov; 63(5):1820-8. PubMed ID: 7931338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of MAO B, but not MAO A, blocks DSP-4 toxicity on central NE neurons.
    Gibson CJ
    Eur J Pharmacol; 1987 Sep; 141(1):135-8. PubMed ID: 3117577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the norepinephrine level by high-performance liquid chromatography to assess the protective effect of MAO-B inhibitors against DSP-4 toxicity.
    Haberle D; Magyar K; Szöko E
    J Chromatogr Sci; 2002 Oct; 40(9):495-9. PubMed ID: 12433110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selegiline can mediate neuronal rescue rather than neuronal protection.
    Tatton WG
    Mov Disord; 1993; 8 Suppl 1():S20-30. PubMed ID: 8302304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evidence of neuroprotection by R(-)-deprenyl and N-(2-hexyl)-N-methylpropargylamine on DSP-4-induced degeneration of rat brain noradrenergic axons and terminals.
    Zhang X; Zuo DM; Davis BA; Boulton AA; Yu PH
    J Neurosci Res; 1996 Feb; 43(4):482-9. PubMed ID: 8699534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical effects of the monoamine neurotoxins DSP-4 and MDMA in specific brain regions of MAO-B-deficient mice.
    Fornai F; Giorgi FS; Gesi M; Chen K; Alessrì MG; Shih JC
    Synapse; 2001 Mar; 39(3):213-21. PubMed ID: 11169770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection by R(-)-deprenyl and N-2-hexyl-N-methylpropargylamine on DSP-4, a neurotoxin, induced degeneration of noradrenergic neurons in the rat locus coeruleus.
    Zhang X; Zuo DM; Yu PH
    Neurosci Lett; 1995 Feb; 186(1):45-8. PubMed ID: 7540268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular pharmacology of L-deprenyl.
    Gerlach M; Riederer P; Youdim MB
    Eur J Pharmacol; 1992 Jun; 226(2):97-108. PubMed ID: 1639115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical and neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine-like monoamine oxidase B inhibitors.
    Yu PH; Davis BA; Durden DA; Barber A; Terleckyj I; Nicklas WG; Boulton AA
    J Neurochem; 1994 Feb; 62(2):697-704. PubMed ID: 8294932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in Parkinson's disease.
    Youdim MB; Riederer P
    Mov Disord; 1993; 8 Suppl 1():S8-13. PubMed ID: 8302308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of selegiline against selective neurotoxins].
    Magyar K
    Vopr Med Khim; 1997; 43(6):504-14. PubMed ID: 9503567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
    Magyar K; Szende B
    Neurotoxicology; 2004 Jan; 25(1-2):233-42. PubMed ID: 14697898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells.
    Inaba-Hasegawa K; Akao Y; Maruyama W; Naoi M
    J Neural Transm (Vienna); 2013 Mar; 120(3):435-44. PubMed ID: 22968599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
    Klegeris A; McGeer PL
    Exp Neurol; 2000 Dec; 166(2):458-64. PubMed ID: 11085911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the pharmacology of selegiline.
    Heinonen EH; Lammintausta R
    Acta Neurol Scand Suppl; 1991; 136():44-59. PubMed ID: 1686954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuroprotective and neuronal rescue effects of (-)-deprenyl.
    Magyar K; Szende B; Lengyel J; Tarczali J; Szatmáry I
    J Neural Transm Suppl; 1998; 52():109-23. PubMed ID: 9564614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective actions of selegiline.
    Ebadi M; Sharma S; Shavali S; El Refaey H
    J Neurosci Res; 2002 Feb; 67(3):285-9. PubMed ID: 11813232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.